Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Oct-Dec;11(4):373-377.
doi: 10.4103/1817-1745.199462.

Neuroblastoma presenting as opsoclonus-myoclonus: A series of six cases and review of literature

Jagdish P Meena  1 , Rachna Seth  1 , Biswaroop Chakrabarty  1 , Sheffali Gulati  1 , Sandeep Agrawala  2 , Priyanka Naranje  3
Affiliations
Case Reports

Neuroblastoma presenting as opsoclonus-myoclonus: A series of six cases and review of literature

Jagdish P Meena et al. J Pediatr Neurosci. 2016 Oct-Dec.

Abstract

The opsoclonus-myoclonus ataxia syndrome (OMAS) also called "Kinsbourne syndrome" or "dancing eye syndrome" is a rare but serious disorder characterized by opsoclonus, myoclonus, and ataxia, along with extreme irritability and behavioural changes. Data on its epidemiology, clinical features, and outcome are limited worldwide. The aim of the study was to evaluate the clinical profile and outcome of children with OMAS. A retrospective data of all children presented to Pediatric oncology clinic with a diagnosis of opsoclonus-myoclonus from 2013 to 2016 were collected. 6 patients with a diagnosis of OMAS were presented over a 4-year period. All 6 cases had paraneoplastic etiology. All Children had good outcome without any relapse. Paraneoplastic opsoclonus myoclonus had a good outcome in our experience.

Keywords: Children; neuroblastoma; opsoclonus-myoclonus-ataxia syndrome; paraneoplastic syndrome.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(Case 2) (Original) Axial section showing well-defined enhancing soft-tissue mass lesion (3.5 cm × 2 cm × 1.4 cm) seen in the left upper psoas muscle extending into left neural foramen in between L2 and L3 vertebra up to dura mater
Figure 2
Figure 2
(a and b) (Case 3) Axial section and coronal section showing right paravertebral mass of size 1.5 cm × 0.6 cm × 2.4 cm at the level of D6 to D8 vertebral body
Figure 3
Figure 3
(a and b) (Case 5) Axial and coronal section showing well-defined left paravertebral mass lesion 2 cm × 1.8 cm × 2.9 cm at the level of D6 to D8 vertebral body
See this image and copyright information in PMC

References

    1. Digre KB. Opsoclonus in adults. Report of three cases and review of the literature. Arch Neurol. 1986;43:1165–75. - PubMed
    1. Pranzatelli MR. The neurobiology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol. 1992;15:186–228. - PubMed
    1. Rudnick E, Khakoo Y, Antunes NL, Seeger RC, Brodeur GM, Shimada H, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies-a report from the children's cancer group study. Med Pediatr Oncol. 2001;36:612–22. - PubMed
    1. De Grandis E, Parodi S, Conte M, Angelini P, Battaglia F, Gandolfo C, et al. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics. 2009;40:103–11. - PubMed
    1. Russo C, Cohn SL, Petruzzi MJ, de Alarcon PA. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: A report from the Pediatric Oncology Group. Med Pediatr Oncol. 1997;28:284–8. - PubMed

Publication types